Clinical Trial Update: The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma

View source ↗

Summary

This clinical trial update describes a study evaluating PET imaging targeting Granzyme B as a biomarker to predict efficacy and prognosis in natural killer/T-ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type
• Natural Killer T-cell Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: T-NK Cell Lymphoma | Status: NOT_YET_RECRUITING